Md. biopharm to work with another firm on diabetes drug

Germantown-based Intrexon Corp., a synthetic biology firm, now has a research collaboration agreement with another company to work on treatments for diabetes and other health problems. Intrexon will work with Janssen Pharmaceutica NV, one of the Janssen pharmaceutical companies of Johnson & Johnson, to discover and develop Intrexon's ActoBiotics therapies to treat type 2 diabetes, obesity ...

Leave a Reply

Your email address will not be published. Required fields are marked *